ICL Acquires Bartek, 2025 Sales Hit $7.153B, Q4 Sales Up 6%
ICL’s acquisition of Bartek Ingredients extends its specialty food portfolio across 40+ countries while full-year 2025 sales reached $7.153 billion (+5%), EBITDA was $1.488 billion and adjusted EPS $0.36. Q4 sales rose 6% to $1.701 billion with EBITDA up 10%, as 2026 guidance forecasts $1.4–1.6 billion EBITDA and 4.5–4.7 million tonnes of potash.
1. Acquisition and Portfolio Expansion
In January the company completed its acquisition of Bartek Ingredients, a global leader in food-grade malic and fumaric acids with distribution in over 40 countries, strengthening its Specialty Food Solutions segment and leveraging existing food ingredient channels for expanded market penetration.
2. Full-Year 2025 Financial Performance
Full-year 2025 sales reached $7.153 billion, up 5% year-over-year, with EBITDA of $1.488 billion, adjusted diluted EPS of $0.36 and operating cash flow of $1.056 billion, driven by pricing contributions despite volume declines, raw material inflation and currency movements.
3. Q4 2025 Results and Segment Highlights
Q4 sales climbed 6% to $1.701 billion, adjusted EBITDA rose 10% to $380 million and adjusted EPS increased 13% to $0.09, supported by a 12% potash sales rise at $348 CIF per ton, 6% industrial products growth and a 25% decline in ocean freight rates.
4. 2026 Outlook and Key Risks
For 2026 the company guides consolidated EBITDA of $1.4–1.6 billion and potash volumes of 4.5–4.7 million tonnes while highlighting headwinds from sulfur costs above $500 per ton and potential $10 million impact per 1% shekel appreciation, with roughly 50% of FX exposure hedged.